Agree with you on buyout, think mid 20's to low 30's depending on when. Japan will be a nice addition to income stream, but we'll be receiving royalties there and uptake will be gradual. But successful use in Japan may encourage off label use elsewhere prior to FDA approvals, which won't happen until 2022 earliest.
Perry's mention of talks with "someone" on cosmetic use I still find very interesting. Hopefully we'll be hearing more on that soon. That market isn't in anyone's projections to date.
Think the next 12-18 months will have it's ups and downs, gradually continuing upward. Should make Mike and Watch happy. Over 90% of my shares are in a cash account, so no trading for me except for the few I have in tax sheltered accounts.
Good to hear from you tdeck, hope you're doing well.
News 
Market Data 
Discover 
